SciHub
文献互助
期刊查询
一搜即达
科研导航
即时热点
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!
小谷
Lv1
100 积分
2022-08-18 加入
最近求助
最近应助
互助留言
《Journal of Thoracic Oncology》:Genomic profiles of pathogenic and moderate-penetrance germline variants associated with risk of early-onset lung adenocarcinoma
1天前
已完结
Clinicopathologic characteristics and follow up outcomes of invasive breast carcinoma with different positive HER2 fluorescence in situ hybridization patterns: experience from a single academic institution
4个月前
已完结
Long-Term Follow-Up of HER2-Positive Breast Cancer Patients Treated with Neoadjuvant Therapy
4个月前
已关闭
Tutt ANJ et al. Adjuvant olaparib for patients with BRCA1- or BRCA2-mutated breast cancer
6个月前
已完结
Targeting SNRNP200-induced splicing dysregulation offers an immunotherapy opportunity for glycolytic triple-negative breast cancer
6个月前
已完结
Overall Survival with Pembrolizumab in Early-Stage Triple-Negative Breast Cancer
7个月前
已完结
Comparative efficacy of anthracycline-free and anthracycline-containing neoadjuvant chemoimmunotherapy regimens for triple-negative breast cancer
8个月前
已完结
没有进行任何应助
帮大忙了
6个月前
速度真快,感谢,点赞
7个月前
谢谢!
8个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论